Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -3,450 | -2,554 | -1,158 | -1,850 |
| Depreciation Amortization | 145 | 103 | 223 | 390 |
| Accounts receivable | 151 | 190 | 87 | N/A |
| Accounts payable and accrued liabilities | -449 | -487 | 318 | N/A |
| Other Working Capital | -229 | -318 | 571 | 850 |
| Other Operating Activity | 1,034 | 973 | -132 | 210 |
| Operating Cash Flow | $-2,798 | $-2,093 | $-91 | $-400 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -198 | -17 | -2 | -3 |
| Purchase Sale Intangibles | -53 | 0 | N/A | N/A |
| Other Investing Activity | -53 | 0 | 0 | -257 |
| Investing Cash Flow | $-251 | $-17 | $-2 | $-260 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 5,781 | 5,702 | N/A | N/A |
| Debt Repayment | -52 | -52 | N/A | N/A |
| Common Stock Issued | 149 | 23 | N/A | N/A |
| Other Financing Activity | 0 | 78 | -165 | 900 |
| Financing Cash Flow | $5,878 | $5,751 | $-165 | $900 |
| Beginning Cash Position | 350 | 351 | 351 | 110 |
| End Cash Position | 3,179 | 3,992 | 93 | 350 |
| Net Cash Flow | $2,829 | $3,641 | $-258 | $230 |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,798 | -2,093 | -91 | -400 |
| Capital Expenditure | -198 | -17 | -2 | N/A |
| Free Cash Flow | -2,996 | -2,110 | -93 | -400 |